Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1970 1
1998 2
2000 2
2001 2
2002 2
2003 7
2004 12
2005 27
2006 13
2007 14
2008 46
2009 23
2010 28
2011 32
2012 31
2013 33
2014 25
2015 34
2016 15
2017 19
2018 27
2019 27
2020 15
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 18178780

387 results
Results by year
Filters applied: . Clear all
Page 1
The OPTIMA study: assessing a new cinacalcet (Sensipar/Mimpara) treatment algorithm for secondary hyperparathyroidism.
Messa P, Macário F, Yaqoob M, Bouman K, Braun J, von Albertini B, Brink H, Maduell F, Graf H, Frazão JM, Bos WJ, Torregrosa V, Saha H, Reichel H, Wilkie M, Zani VJ, Molemans B, Carter D, Locatelli F. Messa P, et al. Clin J Am Soc Nephrol. 2008 Jan;3(1):36-45. doi: 10.2215/CJN.03591006. Clin J Am Soc Nephrol. 2008. PMID: 18178780 Free PMC article. Clinical Trial.
Cinacalcet HCl and concurrent low-dose vitamin D improves treatment of secondary hyperparathyroidism in dialysis patients compared with vitamin D alone: the ACHIEVE study results.
Fishbane S, Shapiro WB, Corry DB, Vicks SL, Roppolo M, Rappaport K, Ling X, Goodman WG, Turner S, Charytan C. Fishbane S, et al. Clin J Am Soc Nephrol. 2008 Nov;3(6):1718-25. doi: 10.2215/CJN.01040308. Clin J Am Soc Nephrol. 2008. PMID: 18945995 Free PMC article. Clinical Trial.
Cinacalcet HCl, an oral calcimimetic agent for the treatment of secondary hyperparathyroidism in hemodialysis and peritoneal dialysis: a randomized, double-blind, multicenter study.
Lindberg JS, Culleton B, Wong G, Borah MF, Clark RV, Shapiro WB, Roger SD, Husserl FE, Klassen PS, Guo MD, Albizem MB, Coburn JW. Lindberg JS, et al. J Am Soc Nephrol. 2005 Mar;16(3):800-7. doi: 10.1681/ASN.2004060512. Epub 2005 Feb 2. J Am Soc Nephrol. 2005. PMID: 15689407 Free article. Clinical Trial.
Cinacalcet hydrochloride therapy for secondary hyperparathyroidism in hemodialysis patients.
El-Shafey EM, Alsahow AE, Alsaran K, Sabry AA, Atia M. El-Shafey EM, et al. Ther Apher Dial. 2011 Dec;15(6):547-55. doi: 10.1111/j.1744-9987.2011.00994.x. Ther Apher Dial. 2011. PMID: 22107691 Clinical Trial.
Combined therapy with cinacalcet and low doses of vitamin D sterols in patients with moderate to severe secondary hyperparathyroidism.
Block GA, Zeig S, Sugihara J, Chertow GM, Chi EM, Turner SA, Bushinsky DA; TARGET Investigators. Block GA, et al. Nephrol Dial Transplant. 2008 Jul;23(7):2311-8. doi: 10.1093/ndt/gfn026. Epub 2008 Feb 29. Nephrol Dial Transplant. 2008. PMID: 18310602 Clinical Trial.
Impact of vitamin D dose on biochemical parameters in patients with secondary hyperparathyroidism receiving cinacalcet.
Wilkie M, Pontoriero G, Macário F, Yaqoob M, Bouman K, Braun J, von Albertini B, Brink H, Maduell F, Graf H, Frazão JM, Bos WJ, Torregrosa V, Saha H, Reichel H, Zani VJ, Carter D, Messa P. Wilkie M, et al. Nephron Clin Pract. 2009;112(1):c41-50. doi: 10.1159/000212102. Epub 2009 Apr 10. Nephron Clin Pract. 2009. PMID: 19365139 Clinical Trial.
Economic analysis of cinacalcet in combination with low-dose vitamin D versus flexible-dose vitamin D in treating secondary hyperparathyroidism in hemodialysis patients.
Shireman TI, Almehmi A, Wetmore JB, Lu J, Pregenzer M, Quarles LD. Shireman TI, et al. Am J Kidney Dis. 2010 Dec;56(6):1108-16. doi: 10.1053/j.ajkd.2010.07.012. Epub 2010 Oct 15. Am J Kidney Dis. 2010. PMID: 20951487 Clinical Trial.
Cinacalcet use patterns and effect on laboratory values and other medications in a large dialysis organization, 2004 through 2006.
St Peter WL, Li Q, Liu J, Persky M, Nieman K, Arko C, Block GA. St Peter WL, et al. Clin J Am Soc Nephrol. 2009 Feb;4(2):354-60. doi: 10.2215/CJN.05241008. Epub 2009 Jan 7. Clin J Am Soc Nephrol. 2009. PMID: 19129318 Free PMC article.
Early initiation of cinacalcet for the treatment of secondary hyperparathyroidism in hemodialysis patients: a three-year clinical experience.
Lucchi L, Carboni C, Stipo L, Malaguti V, Ferrari F, Graziani R, Arletti S, Graziosi C. Lucchi L, et al. Artif Organs. 2011 Dec;35(12):1186-93. doi: 10.1111/j.1525-1594.2011.01270.x. Epub 2011 Aug 17. Artif Organs. 2011. PMID: 21848793
Cinacalcet HCl: a novel treatment for secondary hyperparathyroidism caused by chronic kidney disease.
Torres PU. Torres PU. J Ren Nutr. 2006 Jul;16(3):253-8. doi: 10.1053/j.jrn.2006.04.010. J Ren Nutr. 2006. PMID: 16825031 Review.
387 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback